These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 80873
1. Current concepts in management of testicular tumor. Javadpour N. Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873 [No Abstract] [Full Text] [Related]
2. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE. N Engl J Med; 1976 Nov 25; 295(22):1237-40. PubMed ID: 62281 [No Abstract] [Full Text] [Related]
3. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors. Lange PH. Natl Cancer Inst Monogr; 1978 Dec 25; (49):215-7. PubMed ID: 86163 [Abstract] [Full Text] [Related]
4. The current management of advanced testicular cancers. Wajsman Z, Murphy GP. Urol Surv; 1978 Aug 25; 28(4):127-33. PubMed ID: 81558 [No Abstract] [Full Text] [Related]
6. The role of biologic tumor markers in testicular cancer. Javadpour N. Cancer; 1980 Apr 15; 45(7 Suppl):1755-61. PubMed ID: 6154517 [No Abstract] [Full Text] [Related]
7. [Determination of specific markers in the blood in tumors of the testis]. Sakalo VS, Klimenko IA, Iaremko VN, Zaparin VK. Klin Khir (1962); 1990 Apr 15; (5):47-8. PubMed ID: 1697352 [No Abstract] [Full Text] [Related]
8. Serum alpha fetoprotein and testicular tumors. N Engl J Med; 1977 Mar 24; 296(12):693-4. PubMed ID: 65733 [No Abstract] [Full Text] [Related]
9. Treatment of seminoma: does a positive HCG influence prognosis? Bartsch G, Mikuz G, Frommhold H, Scheiber K. Prog Clin Biol Res; 1985 Mar 24; 203():483-4. PubMed ID: 2421340 [No Abstract] [Full Text] [Related]
10. Applications of biologic tumor markers in testicular cancer. Javadpour N. Cancer Treat Rep; 1979 Mar 24; 63(9-10):1643-7. PubMed ID: 91433 [Abstract] [Full Text] [Related]
11. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis. Scardino PT, Cox HD, Waldmann TA, Mcintire KR, Mittemeyer B, Javadpour N. J Urol; 1977 Dec 24; 118(6):994-9. PubMed ID: 72833 [No Abstract] [Full Text] [Related]
13. [Treatment of stage I, II testicular tumor based on tumor markers]. Kamidono S, Arakawa S, Hamami G, Umezu K, Fujii A, Ishigami J. Nihon Hinyokika Gakkai Zasshi; 1983 Aug 24; 74(8):1383-93. PubMed ID: 6202917 [No Abstract] [Full Text] [Related]
14. [Diagnostic progress in testicular carcinoma]. Aiginger P, Kolbe H, Kühböck J, Spona J. Acta Med Austriaca; 1978 Aug 24; 5(4-5):159-61. PubMed ID: 91300 [Abstract] [Full Text] [Related]
17. Current concepts on the histogenesis, pathology, and immunochemistry of germ cell tumors of the testis. Nochomovitz LE, Rosai J. Pathol Annu; 1978 Aug 24; 13 Pt 1():327-62. PubMed ID: 82931 [No Abstract] [Full Text] [Related]
18. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours. Newlands ES, Dent J, Kardana A, Searle F, Bagshawe KD. Lancet; 1976 Oct 02; 2(7988):744-5. PubMed ID: 61427 [No Abstract] [Full Text] [Related]
19. [Biological markers in testicular cancer]. Glait HM, Carugati A, Scorticati C, Koss A, Bellora O, Mickiewicz E, Arturi J, Olivari AJ. Medicina (B Aires); 1982 Oct 02; 42(5):488-94. PubMed ID: 6188940 [No Abstract] [Full Text] [Related]